Anzeige
Mehr »
Freitag, 20.03.2026 - Börsentäglich über 12.000 News
Drohnen statt Panzer: Beginnt hier der nächste Milliarden-Superzyklus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16:34Sally Beauty Bets on TikTok Shop to Strengthen Omnichannel Strategy
16:34T. Rowe Price Broadens Alternative Investment Suite With OFLEX Launch
16:34COIN vs. GOLD: Which Alternative-Asset Platform is the Better Buy?
15:34Hecla Mining's Cash Strength: Can Shareholder Rewards Keep Rising?
15:34GE Aerospace vs. Textron: Which Aerospace & Defense Stock Should You Bet On?
15:34META Taps AI to Boost Safety Features: Ad Revenues to Grow?
15:34AMD Relies on a Rich Partner Base to Drive Sales: More Upside Ahead?
15:34Lumentum vs. Amphenol: Which AI Connectivity Stock is the Better Buy?
15:34Microsoft vs. Adobe: Which Software Giant Has Better Upside Potential?
15:34Alibaba Q3 Earnings Miss Estimates, Revenues Rise Y/Y
15:10Teradyne Benefits From Strong UltraFLEXplus Demand: More Upside Ahead?
15:10QCOM Hikes Dividend on Solid Cash Flow: Should You Stay Invested?
15:10Sarepta Plans FDA Filings Seeking Full Approval for Two DMD Therapies
15:10Itron & Ausgrid Tackle Solar Surge With Intelligent Grid Management
15:10Cadence and NVIDIA Redefining Chip Design With Agentic AI: Here's How
15:10Lands' End's Q4 Earnings Miss, U.S. Digital Segment Sales Up 5.3%
15:10Caterpillar vs. Komatsu: Which Equipment Stock Has the Edge Now?
15:10DoorDash vs. Shopify: Which E-Commerce Stock Has an Edge Now?
14:34Rising Big Data Market Aids TRU Amid Seasonality & High Rivalry
14:34Can AT&T's App to Enhance Customer Satisfaction Drive Growth?
14:34CAVA Margins Face Salmon Pressure: Near-Term Pain, Long-Term Gain?
14:34Are Acquisitions Expanding MasTec's Reach in Infrastructure Markets?
14:34PFE Talzenna Combo Shows Strong Efficacy in Wider Prostate Cancer Use
14:10How Multi-Year Agreements De-Risk Modine's Growth Story
13:10Bet on These 5 Low-Leverage Stocks as Middle East Conflict Goes On